The post Trump declares global tariff hike to 15% following court setback appeared on BitcoinEthereumNews.com. President Donald Trump announced Saturday an immediateThe post Trump declares global tariff hike to 15% following court setback appeared on BitcoinEthereumNews.com. President Donald Trump announced Saturday an immediate

Trump declares global tariff hike to 15% following court setback

President Donald Trump announced Saturday an immediate increase in the global tariff from 10% to 15% in a move widely seen as a response to a court decision on Friday that struck down certain duties he imposed under the International Emergency Economic Powers Act (IEEPA).

Trump unveiled the new rate in a post on Truth Social, stating that the move is within his lawful authority. The US’ chief executive also noted that the administration will soon establish additional tariff measures to advance his trade agenda.

That came shortly after Trump asserted that existing national security and trade enforcement tariffs would stay in place despite the Supreme Court ruling.

The 6-3 ruling prompted the White House to shift its legal footing to Section 122 of the Trade Act, which grants the president authority to impose temporary import levies.

The administration has relied heavily on import taxes as a tool for shielding American manufacturers amid persistent global trade friction. Levies on steel, aluminum, automobiles, and copper enacted earlier remain in effect, while energy products and pharmaceuticals are carved out of the broader measures.

Since returning to office in January 2025, the president has pursued an aggressive stance on cross-border commerce, targeting goods from China, Canada, and Mexico. Officials have framed the strategy as a means of shrinking the trade gap, generating federal revenue, and bolstering domestic employment.

The White House has also initiated investigations into what it characterizes as unfair practices by specific trading partners, signaling that additional action could follow.

Source: https://cryptobriefing.com/trump-legal-tariffs-new-plans/

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$3,469
$3,469$3,469
-1,56%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

        Highlights:  Inflows of altcoins in exchanges have surged by 22% in early 2026. An increase in deposits indicates a growing sell-side pressure. The 
Share
Coinstats2026/02/22 02:03